Loading
Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes / Treatment of Major Depression · Journal article
International Journal of Pharmaceutical Quality Assurance · July 10, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a single-centre retrospective descriptive study of 90 GAD patients from India reporting demographic and clinical characteristics. It provides a snapshot of treatment patterns and symptom severity in one hospital setting but carries no comparator, does not test an intervention, and does not measure clinical outcomes such as remission or functional recovery.
Retrospective observational study. Patients aged 18–65 years with GAD (DSM-IV diagnosis) attending the Department of Psychiatry, Netaji Subhas Medical College and Hospital, Patna.. n = 90. Netaji Subhas Medical College and Hospital, Patna, India..
31.1% of patients were aged 31–40 years; 55.6% were male; 64.4% were married. 38.9% experienced symptoms for 1–3 years; 55.6% reported sleep disturbances. 44.4% had moderate anxiety (GAD-7 score 15–19); severe anxiety more frequent in older adults.
55.6% received pharmacotherapy alone; 66.7% were prescribed antidepressants.
This descriptive study provides a clinical profile of GAD presentation in one Indian hospital setting but does not test treatment efficacy or measure patient outcomes. It is useful for documenting epidemiological patterns but does not inform evidence-based treatment decisions or change practice.
Single-centre retrospective observational study describing clinical characteristics and treatment patterns in GAD; no control group, no intervention testing, and no hard clinical outcomes reported.
As stated by the source record.
Quoted from the source exactly as published.
This descriptive study provides a clinical profile of GAD presentation in one Indian hospital setting but does not test treatment efficacy or measure patient outcomes. It is useful for documenting epidemiological patterns but does not inform evidence-based treatment decisions or change practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Background: Generalized Anxiety Disorder (GAD) is a prevalent and disabling psychiatric condition ‘ that often remains under recognized, leading to chronic distress and functional impairment. Aim: To evaluate the clinical characteristics, severity, and treatment patterns of patients with GAD attending a tertiary care hospital. Methodology: A retrospective observational study was conducted at the Department of Psychiatry, Netaji Subhas Medical College and Hospital, Patna. Medical records of 90 patients aged 18–65 years, diagnosed with GAD based on DSM-IV criteria, were analyzed. Sociodemographic data, clinical features, comorbidities, GAD-7 scores, and treatment history were extracted and statistically analyzed. Results: The majority of patients were aged 31–40 years (31.1%), males (55.6%), and married (64.4%). Most experienced symptoms for 1–3 years (38.9%) and reported sleep disturbances (55.6%). Moderate anxiety (GAD7 score 15–19) was most common (44.4%), while severe anxiety was more frequent in older adults. Pharmacotherapy alone was the predominant treatment (55.6%), with antidepressants prescribed to 66.7% of patients. Comorbid depression was present in 16.7% of participants. Conclusion: GAD in this tertiary care cohort primarily affects middle-aged adults, presents with moderate severity, and often involves sleep disturbances. Early recognition, assessment of comorbidities, and integrated pharmacological and psychotherapeutic interventions are crucial for improving patient outcomes.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.